Lars Bode
8Patents
2h-index
16Co-inventors
44Inventor score
Filing activity: May 27, 2003 → Jun 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7851450B2 | Gangliosides with a modified acyl function | Human Necessities | 5 | Active |
| US9290530B2 | Chemoenzymatic synthesis of heparin and heparan sulfate analogs | Chemistry; Metallurgy | 2 | Active |
| US9675649B2 | Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease | Physics | 2 | Active |
| US10160986B2 | Chemoenzymatic synthesis of heparin and heparan sulfate analogs | Chemistry; Metallurgy | 1 | Active |
| US11234992B2 | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides | Human Necessities | 1 | Active |
| US10315389B2 | Semi-finished product, method for producing a semi-finished product and use thereof | Performing Operations; Transporting | 0 | Active |
| US10987718B2 | Method for production of a supporting member and a ladder frame or box frame | Performing Operations; Transporting | 0 | Active |
| US11896603B2 | Oligosaccharide as therapeutic agent for alcohol associated liver disease | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.